School of Medicine

Long-term use of a new drug, toferson, approved by the FDA for a rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some patients, according to a study by WashU Medicine researchers and collaborators.

Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor and head of the WashU Medicine Department of Biochemistry and Molecular Biophysics, has received the American Chemical Society’s 2025 Saint Louis Section Award.

The National Academy of Inventors has elected two Washington University in St. Louis faculty members to its 2025 cohort of fellows: Jennifer N. Silva, MD, and Lan Yang.

WashU Medicine researchers show that psychedelic compounds such as psilocybin appear to distort the link between blood flow and brain-cell functioning, which scientists use to track brain activity.

Researchers at WashU Medicine Mallinckrodt Institute of Radiology have received a $5 million grant from the National Institutes of Health (NIH) to study how patterns of brain aging and degeneration mirror early-life experiences.

Naresha Saligrama, of WashU Medicine, led a multi-institution team that uncovered important differences between human T cells that live in specific tissues and T cells found in the blood, with major implications for future research and diagnostics.

With a joint award from the Helmsley Charitable Trust, WashU Medicine and Emory University researchers will develop artificial intelligence software tools to improve diagnosis and treatment of a common complication of Crohn’s disease.

In his role as head student coach at WashU Medicine, Amjad Musleh, MD, an associate professor of anesthesiology and of emergency medicine, mentors aspiring physicians in compassionate care.

Jonathan B. Losos, PhD, and Charles F. Zorumski, MD, are the recipients of Washington University in St. Louis’ 2025 faculty achievement awards, according to Chancellor Andrew D. Martin. They were among several people recognized during WashU’s annual Founders Day celebration.

A study from researchers at Washington University in St. Louis has found connections between the alternative sweetener sorbitol and liver disease.